Eastern Hepatobiliary Surgery Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Established: 1956-01-01

Employees: -

Market Cap: -

Website: http://www.ehbh.cn/

Clinical Trials

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Not Applicable

Conditions: Hepatocellular Carcinoma

Interventions: Drug: FOLFOX4(infusional fluorouracil [FU], leucovorin [LV], and oxaliplatin [OXA]).

First Posted Date: 2020-08-20

Last Posted Date: 2020-08-20

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 184

Registration Number: NCT04521491

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma

Not Applicable

Conditions: Portal Vein Occlusion
Cholangiocarcinoma, Perihilar
Liver; Hypertrophy, Acute
Hepatocellular Carcinoma

Interventions: Procedure: PVE with coils plus TAGM
Procedure: PVE with multiple coils

First Posted Date: 2020-05-13

Last Posted Date: 2020-06-17

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 56

Registration Number: NCT04386772

Locations: 🇨🇳
Easter hepatobiliary surgery hospital, Shanghai, Shanghai, China

Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

Phase 2

Conditions: Gallbladder Carcinoma

Interventions: Drug: Apatinib
Drug: Tegafur

First Posted Date: 2018-10-11

Last Posted Date: 2018-10-11

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 138

Registration Number: NCT03702491

Locations: 🇨🇳
xiao qing xiao qing Jiang, Shanghai, Shanghai, China

Prospective Surveillance for Very Early Hepatocellular Carcinoma

Conditions: Carcinoma, Hepatocellular

First Posted Date: 2018-07-17

Last Posted Date: 2020-05-22

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 10000

Registration Number: NCT03588442

Locations: 🇨🇳
The First Hospital Affiliated to AMU (Southwest Hospital), Chongqing, Chongqing, China
🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
🇨🇳
Mengchao Hepatobiliary Surgery Hospital of Fujian Medical University, Fuzhou, Fujian, China

and more 10 locations

Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma

Phase 4

Conditions: Tumor Recurrence
Hepatocellular Carcinoma

Interventions: Drug: Babaodan oral capsule
Drug: Placebo oral capsule

First Posted Date: 2018-05-03

Last Posted Date: 2018-05-03

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 459

Registration Number: NCT03515369

Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Diagnostic Test: PIVKA-II

First Posted Date: 2017-02-09

Last Posted Date: 2024-02-20

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 4005

Registration Number: NCT03047603

Locations: 🇨🇳
Eastern hepatobiliary surgery hospital, Shanghai, Shanghai, China

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

Not Applicable

Completed

Conditions: Recurrent Hepatocellular Carcinoma

Interventions: Procedure: TACE
Procedure: Hepatectomy

First Posted Date: 2016-04-05

Last Posted Date: 2016-04-05

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 150

Registration Number: NCT02728219

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

Not Applicable

Completed

Conditions: Very-early Stage
Hepatocellular Carcinoma

Interventions: Procedure: MWV
Procedure: RFA
Procedure: PEI

First Posted Date: 2016-04-05

Last Posted Date: 2016-04-05

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 300

Registration Number: NCT02728193

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology

Completed

Conditions: Cancer Stem Cells
Postoperative Recurrence and Metastasis
Hepatocellular Carcinoma

First Posted Date: 2016-04-04

Last Posted Date: 2016-04-04

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 1000

Registration Number: NCT02727673

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC

Phase 1

Completed

Conditions: Rapamycin
Hepatocellular Carcinoma

Interventions: Drug: Rapamycin

First Posted Date: 2016-03-31

Last Posted Date: 2016-03-31

Lead Sponsor: Eastern Hepatobiliary Surgery Hospital

Target Recruit Count: 300

Registration Number: NCT02724332

Locations: 🇨🇳
Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy